More
    Guided Solutions - Connecting Talent With Innovation/div>

    Annoviant wins $2.9m NIH grant for paediatric heart conduits

    US-based medtech startup Annoviant has received a $2.9m grant from the US National Institutes of Health (NIH) to fund the development and commercialisation of...

    Allurion closes $48 million financing

    Allurion closed a financing of convertible senior secured notes worth $48 million. The company entered into the financing with certain entities managed by RTW...

    Elucent Medical receives over $42 million in funding

    Elucent Medical, a medical technology company headquartered in Eden Prairie and focused on the field of surgical navigation, recently successfully completed a $42.5 million...

    Nectero Medical closes $96M Series D

    Nectero Medical announced it closed a Series D financing round worth proceeds of $96 million. Norwest Venture Partners led the round. Boston Scientific, BioStar...

    Prothea debuts with $13m to develop cancer diagnostics and treatment

    The University of Edinburgh and Bath spin-off, Prothea Technologies, has closed €12m ($13m) in Series A financing to develop cancer diagnostics and therapeutics. The company...

    Biolinq raises $58m for glucose microsensor pivotal trial

    Biolinq has raised $58m in a financing round to support an ongoing pivotal trial investigating its wearable, non-invasive glucose sensor patch. Biolinq’s CEO Richard Yang...

    Neurava raises $2.3 Million for epilepsy monitoring technology

    Neurava announced today that it completed an oversubscribed seed financing round worth proceeds of $2.26 million. Indianapolis-based Neurava develops a novel wearable device for mitigating...

    EarliTec Diagnostics, Inc. Raises $21.5M in Series B Financing

    EarliTec Diagnostics, Inc. (“EarliTec”), a medical device company focused on diagnostic and therapeutic solutions for children with autism and related early childhood vulnerabilities, announced...

    ViaLase closes $40M series C financing to advance first femtosecond laser for Glaucoma treatment

    ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced that it has closed...

    Latest articles